Profile
Cheryl Zimberlin is currently the Director at Indi Molecular, Inc. and the Principal at Merck Ventures BV.
She previously worked as a Member-Supervisory Board at Vaximm AG.
Cheryl Zimberlin active positions
| Companies | Position | Start |
|---|---|---|
Merck Ventures BV
Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/04/2019 |
Indi Molecular, Inc.
Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents | Director/Board Member | - |
Former positions of Cheryl Zimberlin
| Companies | Position | End |
|---|---|---|
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Commercial Services |
Indi Molecular, Inc.
Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents | Health Technology |
Merck Ventures BV
Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements. | Finance |
- Stock Market
- Insiders
- Cheryl Zimberlin
















